[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582952":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":25,"responsibleParty":90,"collaborators":10,"id":92,"slug":10,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":95,"acronym":10,"eligibilityCriteria":96,"healthyVolunteers":93,"sex":97,"minAge":10,"maxAge":98,"enrollmentInfo":99,"targetDuration":10,"studyType":102,"phases":10,"briefSummary":103,"conditions":104,"keywords":109,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Meyer Children's Hospital IRCCS","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Monotherapy",null,"Patients taking only one drug acting on QT interval",{"label":13,"type":10,"description":14,"interventionNames":10},"Monotherapy to monotherapy","Patients who have switched from a drug acting on QT interval to another",{"label":16,"type":10,"description":17,"interventionNames":10},"Polytherapy","Patients taking more than one drug acting on QT interval",[19],{"name":20,"role":21,"phone":22,"phoneExt":23,"email":24},"Tiziana Pisano, MD","CONTACT","3498705830","+39","tiziana.pisano@meyer.it",[26,39,52,62,72,81],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":10},"Neuropsichiatria Infantile, IRCCS - OC Associazione Oasi Maria SS. ONLUS","NOT_YET_RECRUITING","Troina","Enna","94018","Italy",{"type":34,"coordinates":35},"Point",[36,37],14.59605,37.78437,{"lat":37,"lon":36},{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":32,"cosmosGeoPoint":45,"geoPoint":49,"contacts":50},"AOU Meyer IRCCS","RECRUITING","Florence","FI","50139",{"type":34,"coordinates":46},[47,48],11.24626,43.77925,{"lat":48,"lon":47},[51],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":24},{"facility":53,"status":41,"city":54,"state":55,"zip":56,"country":32,"cosmosGeoPoint":57,"geoPoint":61,"contacts":10},"IRCCS Fondazione Stella Maris","Calambrone","Pisa","56128",{"type":34,"coordinates":58},[59,60],10.3,43.58333,{"lat":60,"lon":59},{"facility":63,"status":64,"city":65,"state":10,"zip":66,"country":32,"cosmosGeoPoint":67,"geoPoint":71,"contacts":10},"Neuropsichiatria infantile, Policlinico S.Orsola-Malpighi","ACTIVE_NOT_RECRUITING","Bologna","40138",{"type":34,"coordinates":68},[69,70],11.33875,44.49381,{"lat":70,"lon":69},{"facility":73,"status":28,"city":74,"state":10,"zip":75,"country":32,"cosmosGeoPoint":76,"geoPoint":80,"contacts":10},"Clinica di Neuropsichiatria dell'Infanzia e dell'adolescenza, Ospedale Pediatrico A. Cao ARNAS G. Brotzu","Cagliari","09121",{"type":34,"coordinates":77},[78,79],9.11917,39.23054,{"lat":79,"lon":78},{"facility":82,"status":28,"city":83,"state":10,"zip":84,"country":32,"cosmosGeoPoint":85,"geoPoint":89,"contacts":10},"Neuropsichiatria Infantile, Azienda Ospedaliera-Universitaria \"Gaetano Martino\"","Messina","98124",{"type":34,"coordinates":86},[87,88],15.55256,38.19394,{"lat":88,"lon":87},{"type":91,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100582952",false,"NCT06870006","Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population","Inclusion Criteria:\n\n* Admitted to psychiatry ward\n* Starting a psychotropic drug acting on QT interval\n\nExclusion Criteria:\n\n* Age \\>18aa\n* History of administration of drug acting on QT interval in the 3 months prior","ALL","18 Years",{"count":100,"type":101},100,"ESTIMATED","OBSERVATIONAL","Electrocardiogram (ECG) Q-T prolongation is a cardiac electrophysiological disorder associated with the occurrence of arrhythmias potentially fatal. Several psychotropic drugs are associated with an increased risk of QT prolongation, which is why in clinical practice a baseline ECG is performed before a psychotropic drug is prescribed. However, there are no validated protocols establishing when to repeat this examination or describing clinical events when this examination should be repeated in clinical follow-up.\n\nThe study aims to investigate the incidence of QTc prolongation events as a side effect of chronic psychotropic drug administration. For this purpose, ECGs will be recorded and confounding factors of patients at the beginning of psychotropic therapy and after 3, 6 and 12 months will be analyzed.",[105,106,107,108],"Eating Disorders","Mood Disorders in Children and Adolescents","Psychotic Disorder","QTc Intervals Changes",[110,111],"QTc interval","psychotropic drugs","2026-03-17",{"date":114,"type":115},"2026-03-18","ACTUAL",{"date":117,"type":115},"2024-01-01",{"date":119,"type":101},"2027-01",{"name":5,"class":6},6]